Fadlo R. Khuri
Fadlo R. Khuri
President and Professor, American University of Beirut
Vahvistettu sähköpostiosoite verkkotunnuksessa aub.edu.lb
Nimike
Viittaukset
Viittaukset
Vuosi
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
15702015
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
14692014
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
13962018
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri, J Nemunaitis, I Ganly, J Arseneau, IF Tannock, L Romel, ...
Nature medicine 6 (8), 879-885, 2000
13252000
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ...
Jama 311 (19), 1998-2006, 2014
12612014
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
10602018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
9542018
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun, LM Rosenberg, X Wang, Z Zhou, P Yue, H Fu, FR Khuri
Cancer research 65 (16), 7052-7058, 2005
8752005
The BATTLE trial: personalizing therapy for lung cancer
ES Kim, RS Herbst, II Wistuba, JJ Lee, GR Blumenschein, A Tsao, ...
Cancer discovery 1 (1), 44-53, 2011
8712011
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
SG Swisher, JA Roth, J Nemunaitis, DD Lawrence, BL Kemp, ...
Journal of the National Cancer Institute 91 (9), 763-771, 1999
851*1999
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
8492018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
8442018
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth
T Hitosugi, S Kang, MG Vander Heiden, TW Chung, S Elf, K Lythgoe, ...
Science signaling 2 (97), ra73-ra73, 2009
6732009
Integrated genomic characterization of oesophageal carcinoma
Cancer Genome Atlas Research Network
Nature 541 (7636), 169, 2017
6292017
Perspectives for cancer prevention with natural compounds
ARMR Amin, O Kucuk, FR Khuri, DM Shin
Journal of clinical oncology 27 (16), 2712, 2009
5952009
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
J Nemunaitis, F Khuri, I Ganly, J Arseneau, M Posner, E Vokes, J Kuhn, ...
Journal of Clinical Oncology 19 (2), 289-298, 2001
5852001
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
FR Khuri, H Wu, JJ Lee, BL Kemp, R Lotan, SM Lippman, L Feng, ...
Clinical Cancer Research 7 (4), 861-867, 2001
5722001
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck …
R Haddad, A O'Neill, G Rabinowits, R Tishler, F Khuri, D Adkins, J Clark, ...
The lancet oncology 14 (3), 257-264, 2013
5702013
Clonal genetic alterations in the lungs of current and former smokers
L Mao, JS Lee, JM Kurie, YH Fan, SM Lippman, A Broxson, FR Khuri, ...
Journal of the National Cancer Institute 89 (12), 857-862, 1997
5331997
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial
J Nemunaitis, I Ganly, F Khuri, J Arseneau, J Kuhn, T McCarty, S Landers, ...
Cancer research 60 (22), 6359-6366, 2000
5162000
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20